Skip to Content

Clinical Trial Details

A Randomized Phase III Study Of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone In Untreated Older Patients (= 65 Years Of Age) With Chronic Lymphocytic Leukemia (CLL)

IRB Protocol Number
Alliance A041202

Clinical Trial Categories

  • Lymphoma/Lymph Node/Leukemia/Blood-related Cancers
Barbara Beauchemin, RN, BSN at 603-224-2556


  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000